TXMD TXMD

TherapeuticsMD Stock Price

4.58
0.00 (0.0%)
4.58
Volume 6
Bid Price 4.72
Ask Price 5.20
News -
Day High

Low
0.1503

52 Week Range

High
11.69

Day Low
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.58 07:26:37
Open Price Low Price High Price Close Price Prev Close
4.58
Trades Volume Avg Volume 52 Week Range
1 6 - 0.1503 - 11.69
Last Trade Time Type Quantity Stock Price Currency
04:00:00 6 $ 4.44 USD

Period:

Draw Mode:

TherapeuticsMD Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 43.36M 9.47M 8.73M $ 86.95M $ -6.68M -21.52 -3.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 658.18k 6.50%

more financials information »

TherapeuticsMD News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TXMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.254.91624.204.4979,5180.337.76%
1 Month5.406.984.145.2060,014-0.82-15.19%
3 Months7.959.034.146.3865,365-3.37-42.39%
6 Months9.9311.694.038.57483,152-5.35-53.88%
1 Year0.51111.690.15031.083,579,7734.07796.28%
3 Years2.5611.690.15031.355,266,1582.0278.91%
5 Years6.3011.690.15032.234,334,312-1.72-27.3%

TherapeuticsMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.